Evelo Biosciences Inc (EVLO)

NASDAQ
1.86
-0.15(-7.46%)
  • Volume:
    103,012
  • Day's Range:
    1.80 - 1.99
  • 52 wk Range:
    1.42 - 12.74

EVLO Overview

Prev. Close
2.01
Day's Range
1.8-1.99
Revenue
-
Open
1.99
52 wk Range
1.42-12.74
EPS
-2.08
Volume
103,012
Market Cap
200.87M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
209,071
P/E Ratio
-
Beta
1.57
1-Year Change
-75.1%
Shares Outstanding
107,993,704
Next Earnings Date
Nov 03, 2022
What is your sentiment on Evelo Biosciences?
or
Market is currently closed. Voting is open during market hours.

Evelo Biosciences Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Evelo Biosciences Inc Analysis

Evelo Biosciences Inc Company Profile

Evelo Biosciences Inc Company Profile

Employees
90

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Read More

Analyst Price Target

Average17.75 (+854.30% Upside)
High41.5
Low6
Price1.86
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell